$800 Million Baby !!!

Discussion in 'Acorda Therapeutics' started by anonymous, Feb 16, 2018 at 8:18 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    FYI. The interns were directed to do this to flag their posts to Leadership. This is mandatory if they want credit.
     

  2. anonymous

    anonymous Guest

    It’s only a blessing if you have revenue to cover the gap. With a consensus forecast of $317MM at peak in 2022, you have a problem. As for “prepping” doctors and patients, what makes you think there is a high need for market developmemt here? Are you going to teach people how to inhale? Market development also requires a good med aff team that seems to have been decimated at ACOR.

    Your best bet is to find some desperate company to overpay for this me-too product and move on. Ron may get $800M at 2.5x peak revenue on a sale or $1.1 billion life of product if he’s lucky.
     
  3. anonymous

    anonymous Guest

     
  4. anonymous

    anonymous Guest

    More misinformation. Med Affairs was never decimated. There were some slackers who had to be let go. Leadership canot tolerate slackers !
     
  5. anonymous

    anonymous Guest

    This is very unfair to a number of my MSLss, Med-info and Med Affairs colleagues that were layoff for financial reasons : to now call them "slackers"

    Some had been loyal Acordians since the times when Ampyra wasn't yet approved.

    Face reality: the Launch of Inbrija is at risk, both in terms of effectiveness (uptake) and compliance; now that Med Affairs doesn't have the Leadership of those Mexicans.

    Let's hope that the current Medical Leadership knows how to navigate the turbulent waters of Med Affairs compliance, while delivering an effective Launch. (As the old Team accomplished for Ampyra)
     
  6. anonymous

    anonymous Guest



    Your particular colleagues may not have been in the slacker group. Each employee's value to bottom line is based on the HR guidelines of EVMS for non Leadership rank and file. Simply put if an employee doesn't pull their own weight they could be sacked. Sometimes a PIP is activated to give them a chance to improve their performance.
     
  7. anonymous

    anonymous Guest

    It was not a "particular" colleague - but half of Medical Affairs

    Get real and be fair.

    Medical Affairs was decimated under the current CMO and his side-kick Squillacote

    Unfortunately
     
  8. anonymous

    anonymous Guest

    OK let's be fair

    They obviously did not place much value on Med Aff if they cut it back that much. Our Leadership is very adept at seeing thru the BS.
     
  9. anonymous

    anonymous Guest

    +++++++++++++++++++++++

    LMAO

    +++++++++++++++++++++++
     
  10. anonymous

    anonymous Guest

    The above was posted by a slacker. Yes Leadership sees right thru this blatant post. Colleagues stand up and support our Leaders!
     
  11. anonymous

    anonymous Guest

    What leaders? You mean the people in the nice offices with the high compensation that aren’t accountable? You can hardly call them leaders.

    Given that everyone is rank and file and a slacker when you are done with them, don’t be surprised if there is no engagement here.

    You would make a good propagandist for a dictatorship.
     
  12. anonymous

    anonymous Guest

    yeah right, don’t this say it all about just how patient-driven; life science-focused this massive feeding trough is. what, 30-some posts under this topic and no virtue signaling?

    Helping people (get rich)
    *ahem*
    Helping people
     
  13. anonymous

    anonymous Guest

    **********************
    The jist of many of these posts, unbelievable as it may seem, is that your Leadership is not patient driven. This is totally untrue. Those that post such misinformed opinions should be reminded that our CEO received a score of 94% from Glassdoor. That's an incredibly high level of confidence!
    **********************
     
  14. anonymous

    anonymous Guest

    Back to Glassdoor again? Your reliance on that tells me you like to manipulate that narrative as well.
     
  15. anonymous

    anonymous Guest

    We should be celebrating our great Leadership Team. Quit trying to obscure the truth. Glassdoor is relevant as it is a sounding board of critical posts about a subject company and it's culture, benefits and management. Realize it does not support the negative posts on CP hence your displeasure. Sorry..
     
  16. anonymous

    anonymous Guest

    Why be sorry for getting. Called out on your PR campaign. At least own it.

    Remember, performance matters, not your PR spin. When you hit $800M for your me too inhaled LD you can go on and on about six sigma, leadership, blah blah. Until then, you are talking out your ass.
     
  17. anonymous

    anonymous Guest

    Why so much hatred towards Acorda, Ron, Leadership and the rest of Acordans?

    This is a time in which we should be United and face the dragons, demons at the dungeon.

    We are Acorda. A fantastic company

    We will emerge victorious
    Our patients will be healed
    Our investors well compensated

    I have no doubts

    Let's ALL keep working towards a bright future with determination and optimism. Together.

    Go Acorda!!!!
     
  18. anonymous

    anonymous Guest


    AMEN to those words of encouragement.
     
  19. anonymous

    anonymous Guest

    Thank you. We appreciate our loyal workforce. This will Bea great year for us.
     
  20. anonymous

    anonymous Guest

    Three consecutive posts on a Saturday night! Damn PRincess, you must want that time and a half bad.

    Explain how it’s going to be a good year when Ampyra revenues drop off before October, when the “novel blockbuster” is approved. Meaning of course that you won’t be replacing lost revenue for 18-24 months at best.

    There is only one person that benefits from this charade: your wonderous leader L Ron